Wearables

This channel includes news and new technology innovations for wearable cardiac diagnostic systems. These include technologies related to smart phone apps, wearable monitors, consumer-grade wearables and medical grade FDA cleared wearables. A good overview on the future of these technologies can be found in this article.

Abbott plans to expand the monitoring capabilities of its FreeStyle Libre device to enable people to make healthier decisions. The platform uses a disk that is adhered to the skin and uses wireless communication with the patient's smartphone to transfer data into an app where they can monitor their glucose levels in real time without the need for finger prick blood tests. This wearable technology is now being expanded to other areas of biohealth monitoring.
News | Wearables
Abbott Announces Future of Biowearables at Consumer Electronics Show

January 7, 2022 — Abbott announced it is developing a new category of consumer biowearables called Lingo, which is being ...

Home January 07, 2022
Home
Cardiologs, a leader in artificial intelligence (AI) cardiology diagnostics, announced the results of a clinical study that proved Cardiologs’ deep learning AI outperforms the Apple Watch ECG algorithm in the detection of atrial arrhythmias (AA), which are related to stroke risks. The data was accepted for a moderated digital poster presentation at the American Heart Association (AHA) Scientific Sessions 2021. #AHA ECG Monitoring AI
News | Artificial Intelligence
New Study Shows Cardiologs' Deep Learning AI Outperforms the Apple Watch ECG Algorithm in Detecting Atrial Arrhythmias

November 22, 2021 — Cardiologs, a leader in artificial intelligence (AI) cardiology diagnostics, announced the results ...

Home November 22, 2021
Home
Videos | EP Lab
VIDEO: Advances in Electrophysiology Technology

Christine Albert, M.D., MPH, professor, chair of the Department of Cardiology and the Lee and Harold Kapelovitz ...

Home November 22, 2021
Home
News | Wearables
Novel Algorithm on Wearable Devices Can Detect Irregular Heartbeat, May Prompt Early Care

November 18, 2021 — A novel software algorithm compatible with a wide range of smartwatches and fitness trackers ...

Home November 18, 2021
Home
News | Atrial Fibrillation
Monitoring for Individual Triggers May Reduce Episodes of Atrial Fibrillation

November 17, 2021 — People with atrial fibrillation (AFib) who underwent individualized testing to discover triggers for ...

Home November 17, 2021
Home
The Cardiologs AI-enabled software being used to remotely monitor a cardiac patient. #Telecardiology, cardiac telehealth
News | Remote Monitoring
Philips Expand Cardiac Diagnostics and Monitoring Portfolio With Cardiologs Acquisition

November 20, 2021 – Philips announced it signed an agreement to acquire Cardiologs, a France-based medical technology ...

Home November 09, 2021
Home
The Vagus Breathe ECG app for the Apple Watch is the first test to measure the exact breathing flow with an electrocardiogram (ECG) recording. It uses a 30-second breathing test for wearable device. It is being used to monitor long-COVID patients.
News | Wearables
Apple Watch Adds New Breathing Test Based on ECG Analysis

November 1, 2021 — Health AI company Vagus.co, based in Cambridge, U.K., has launched a 30-second breathing test for ...

Home November 01, 2021
Home
The Biotricity Biocare Cardiac app for the Samsung Galaxy Watch4 offers mobile cardiac telemetry with real-time monitoring and transmission of ECG information. It also can interface with FDA-cleared devices, including a digital thermometer, a pulse oximeter and a blood pressure cuff.
News | Wearables
Biotricity Launches Biocare Cardiac Application for Samsung's Galaxy Watch4 Series

October 15, 2021 — Biotricity Inc. announced the release of Biocare Cardiac, a personal, cardiac health application for ...

Home October 15, 2021
Home
SimpleSense is an FDA cleared remote diagnostic platform. The cloth-based nanosensor technology undergarment monitors multiple patient vitals such as heart rate, blood pressure, respiration rate, and physical activity.
News | Cardiac Diagnostics
FDA Clears Nanowear Platform to Implement AI-based Home Diagnostics and Monitoring Network

October 4, 2021 – Nanowear, a hospital-at-home and remote diagnostic platform that used  proprietary wearable cloth ...

Home October 04, 2021
Home
Gallery | HIMSS | By Dave Fornell, Editor
Photo Gallery of New Technologies at HIMSS 2021

The annual Healthcare Information Management Systems Society (HIMSS) 2021 meeting is the largest health information ...

Home August 18, 2021
Home
The devices compared in the study were the Bardy Carnation Ambulatory Monitor long-term continuous ECG system (left) and the BioGuardian MCT cardiac event monitor (right).  #HRS21 #HRS2021 #HeartRhythm21
News | EP Lab
Human ECG Monitoring Outperforms AI Dependent Remote Cardiac Monitoring

July 29, 2021 – Results from a new clinical trial found human-oversight dependent continuous electrocardiography (ECG) ...

Home July 29, 2021
Home
The BardyDx Carnation Ambulatory Monitor (CAM) is a P-wave centric wearable ambulatory cardiac patch monitoring and arrhythmia detection device. 
News | Cardiac Diagnostics
Bardy Carnation Ambulatory Monitor Patch Decreases Diagnosis Time and Readmissions

July 29, 2021 — A recent clinical study from Overlake Medical Center utilizing the Bardy Diagnostics Carnation ...

Home July 29, 2021
Home
The AcQMap 3D Imaging and Mapping System, left, and the AliveCor KardiaMobile device and app for personal ECG monitoring using a smartphone, right. The companies plan to use remote monitoring to see if it helps improve care for ablation patients.
News | EP Lab
AliveCor and Acutus Partner to Evaluate Arrhythmia Management and Treatment

July 27, 2021 — AliveCor Inc., which offers FDA-cleared, smart-phone enabled personal electrocardiogram (ECG) technology ...

Home July 27, 2021
Home
In the past decade there has been a proliferation of clinical-grade wearable monitors and implantable devices such as pacemakers, ICDs, implantable cardiac monitors, and new pacemaker-like devices that can control hypertension. In the near future, these devices will be tied into a body-wide internet of things for specific patients that can transmit patient data to clinicians wirelessly to enable an integrated, more robust form of telecardiology and telemedicine.
Feature | Telecardiology | Victor Wollesen
Next Generation Cardiac Wearables and Implantables Will Integrate Into Wireless Body Area Networks 

Cardiovascular diseases are among the leading causes of death for people over 65 years old in North America and Europe ...

Home July 23, 2021
Home
The FDA has cleared Angel Medical Systems' second-generation AngelMed Guardian device. The implantable cardiac device detects and warns patients if they are having an acute coronary syndrome (ACS) event, including silent heart attacks. The new, second-generation device is enhanced with ease-of-use adaptations and an updated, long life battery that could potentially double the life of the implanted device
News | Cardiac Diagnostics
FDA Approves AngelMed Enhanced Real-Time Cardiac Monitor for Acute Coronary Syndrome (ACS) Events

July 1, 2021 — The U.S. Food and Drug Administration (FDA) has cleared the Angel Medical Systems Inc. second-generation ...

Home July 01, 2021
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now